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Abstract: 
Numerical simulation of flow through a realistic bifurcated carotid artery geometry 
with a stenosis has been conducted for comparison to experimental measurements. The 
behaviour of simplified therapeutic nanoparticles in relatively low concentration was 
observed using a discrete particle approach. The role of size (diameters from 500 nm 
to 50 nm) in determining particle residence time and the potential for both desirable 
and undesirable wall interactions was investigated. It was found that mean particle 
residence time reduced with decreasing particle diameter, and the percentage of 
particles experiencing one or more wall interactions increased simultaneously. Further 
simulations were conducted on a scaled-down version of the geometry which 
approximated the size and flow conditions of an arteriole with capillary branches, and 
in this instance the mean residence time increased with decreasing particle diameter, 
owing largely to the greater influence of Brownian motion. 33% of all 50 nm particles 
were involved in wall interactions, indicating that smaller particles would have a 
greater ability to target, for instance, cancerous tumours in such regions. 
1. INTRODUCTION 
The use of therapeutic nanoparticles to attack malignant tumors, whether by highly-targeted 
delivery of drugs or by thermal ablation of cancerous tissue, is a technique that has been receiving 
considerable attention in recent years [1], particularly with regards to the role that particle size and 
shape plays. Compared to laboratory and clinical trials, relatively little numerical work has been 
conducted on this problem, and thus the potential for simulation to aid in understanding of particle 
behaviour and design of more effective delivery has been under-exploited. The work presented here 
represents a preliminary study into the extent to which particle size influences transport through 
vasculature at both artery and arteriole/capillary scale. 
The potential to treat tumors directly and in high dosage without inducing undesirable effects on 
the rest of the body is being widely investigated in medicine, and may eventually lead to highly 
effective treatments [1]. However, much of the research to-date presents occasionally-conflicting 
conclusions about the role of particle size and shape, and raises considerable issues with regards to 
safety. For instance, damage from localized hyperthermia from ablative treatments involving 
metallic particles, or toxicity caused by the retention of large concentrations of particles in the 
spleen, liver and other organs [2]. Toxicity, particularly with regards to silver and gold particles 
accumulating in the liver, is partially dependent on particle size, thought to be a result of the larger 
surface area that a set mass of small particles will present [3]. 
Nevertheless, intravascularly-injected particles have proven useful for the early detection, 
imaging and therapy of diseases and have the potential to enable on-time diagnosis, molecularly-
targeted biomedical imaging and the timely delivery of multiple therapeutic agents [1, 4]. The 
general conclusion of clinical trials for particles of varying size is that smaller particles have the 
best ability to reach their target [5], but an incomplete understanding of the reasons for this persists. 
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Beyond the ability to treat a tumour, therapeutic nanoparticles will be required to perform well 
at multiple duties before optimal treatment can be developed. They must be able to travel relatively 
freely and efficiently through the bloodstream until the region of interest, such as a tumor. They 
then are required to target the tumor specifically, such that they will arrive in maximum 
concentration where they are intended. The complex process of infiltrating the cancerous cells to 
deliver drugs or perform ablative duties usually necessitate particles of 500 nm or less penetrating 
the endothelial cells via fenestrated tissue – this is commonly referred to as the enhanced 
permeation and retention effect (EPR). Particles continuing to circulate through the body must also 
eventually be excreted through the kidneys. To perform all these tasks independently, certain sizes 
and shapes, amongst other attributes, of the particles would be preferable. To perform them all 
requires certain compromises that make it likely that no single system of specific size, shape, 
elasticity and targeting properties will suffice for quantitative attack on some targets [6]. 
For transport of a particle in the body, the diameter will, in part, dictate particle velocity, diffusion, 
and adhesion to walls in blood vessels, airways and intestines (and thus the potential for phagocytosis). 
The shape, charge, and chemistry of the particle will influence these properties in more complex ways 
[7], and mechanical stiffness of the particle is also a considerable factor [8]. After administration of 
treatment in rodents, small particles (< 30 nm) are eliminated by renal excretion [9]. Larger particles 
(150–300 nm) are found mainly in the liver and spleen [10, 11], and particles of 30 nm–150 nm 
typically end up in the heart, kidney and stomach [12, 13]. While size is therefore clearly influential for 
both system clearance and biodistribution, it is noted that the parameter is not often well controlled or 
described in literature [5], often due to issues stemming from measurement techniques. 
For targeted applications, the diameter of the particle will affect the degree to which particles fit 
the contours of target cell membranes. Shear induced by blood flow could detach the particle, and 
thus the size will determine the longevity of the targeted attachment. Non-specific interactions (van 
der Waals, electrostatic and steric interactions) with the blood vessel walls are also important to the 
effectiveness of vascular targeting. “Ideal” size requirements for nanoparticles so far developed for 
cancer treatment are between 70 and 200 nm [14]. 
Decuzzi et al. conducted trials on mice in which particles of spherical, hemispherical, cylindrical 
and discoidal shape were injected [2]. The number of particles accumulating in the major organs 
and within the tumour mass was measured using elemental silicon analysis. Smaller spherical 
particles were found to provide a more uniform tissue distribution, but discoidal particles were 
observed to accumulate more than others in most organs bar the liver, where cylindrical particles 
were deposited to a greater extent. The study also indicated that the strength of adhesion of 
spherical beads to biological substrate reduced with increasing particle diameter, meaning larger 
particles would be less likely to resist a shear stress dislodgement force. 
Doshi et al. state that direct observations of carrier flow in blood vessels are very challenging 
due to practical issues associated with visualisation of particles in blood vessels (nanoparticles 
cannot be visualised at an individual level) and isolating contributions from various confounding 
factors [15]. They addressed this challenge by using their synthetic system, though one can see that 
accompanying numerical simulation would be very useful. As with many other experimental 
studies, the hydrodynamic performance of the particles cannot be assessed in detail other than in 
broad generalisations and inferences from the concentrations and final locations of injected 
particles. Micro-meter scale particles (1 µm to 20 µm) were used and can provide advantages over 
nanoparticles for some therapeutic delivery applications, however they are typically larger than 
those used for drug delivery. The effect of shape was amplified at larger particle sizes, which it was 
speculated was due to higher drag or higher settling velocity of larger particles compared to smaller 
ones, and additionally the channel bifurcation produced significantly different flow and adhesion 
behaviour than that observed in a simpler linear channel. 
“Margination dynamics” is a physiological term conventionally used to describe the lateral 
drift of platelets from the core blood vessel towards the endothelial walls. Marginating particles 
can be designed specifically to move preferentially in close proximity to the walls, and this can 
be highly desirable in vascular targeting [16]. Red blood cells exhibit a behaviour opposite to 
margination, with cells accumulating preferentially within the core of the vessels, avoiding 
interaction with the walls. This core accumulation is known as “plasma skimming” and was 
described by Fahraeus and Lindqvist [17]. Particles designed to marginate tend to accumulate in 
the cell-free layer near the walls, and Charoenphol et al. concluded that pulsatility in blood flow 
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further enhanced the margination of microspheres while having minimal effect on the adhesion 
of nanospheres [18]. 
While much of the recent research, as described above, focuses on particle concentrations as a 
function of size and shape or other parameters, this is very much a cause-and-effect analysis that 
does not necessarily yield reliable insight into the importance or otherwise of the hydrodynamics 
of particle transport at any particular point in the circulation. While particle shape has been shown 
to be an important factor in cell adhesion and the surface area is critical for drug-loaded particles, 
it can be expected that, particularly in flowfields where particle diameter is insignificant compared 
to the vasculature in question, the particle trajectory will not be sensitive to this parameter. 
Therefore, this paper concentrates on a preliminary investigation into the role of particle size on the 
particle dynamics in a patient-specific geometry. The primary advantage of this modeling is that the 
particle size and concentration is perfectly controlled, thus removing some of the uncertainty which 
can arise even from well-designed experiments. 
In order to examine numerically the transport of nanoparticles in a in a realistic setting, with a 
simplified model for particle trajectories, a bifurcated carotid artery geometry derived from high-
resolution magnetic resonance imaging was used following the study of Cheung et al. [19]. One arm 
of the bifurcation (the internal carotid artery) features a stenosis as indicated in figure 1, which provides 
the flowfield with a point of constriction and high shear stress, and therefore high local flow velocity. 
The work of Cheung et al. was used as a means of benchmarking the flow solution prior to the 
introduction of particles into the simulation. Their experimental reproduction of the stenosed 
bifurcated artery was scaled up by a factor of ten from the original geometry, in order to allow a 
clear silicone rig of reasonable size to be built for measurements made using particle image 
velocimetry (PIV). From this point on, any reference to the artery refers to this enlarged scale. The 
Reynolds number was kept consistent with that which could be expected at the original scale by 
changing the effective viscosity of the working fluid (kept at a constant  25°C), and the flow was 
steady (non-pulsatile). For more details on the reference experiments, the reader is directed to 
Cheung et al. [19] – it is sufficient here for the sake of brevity to state that all known aspects of the 
experiment have been reproduced numerically as faithfully as possible, with pertinent attributes 
and boundary conditions outlined in table 1. 
Numerical modeling using a commercial fluid dynamics code was used to generate results for the 
laminar flowfield in which the nanoparticle trajectories were calculated according to the approach 
described in section 2. In order to examine the influence of particle diameter on path and residence 
time in more than one scenario, the carotid artery geometry was scaled down to the point at which 
the inlet diameter would approximate an arteriole which would then branch off into capillary 
channels very loosely represented by the artery ICA and ECA branches. The flow conditions were 
chosen to approximate physiological values appropriate to the scale, as shown in table 1. 
Broadly speaking, it is preferable for particles designed for drug delivery to avoid interaction 
with the artery walls so as not to become trapped and/or consumed by the vascular walls, which 
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Common carotid 
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Flow direction 
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Figure 1: The carotid artery geometry. 
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Table 1: Flow conditions. 
Mass flow in Density Dynamic Viscosity 
Geometry (kg/s) (kg/m3) (kg/ms−1) 
Artery (experimental scale) 0.253 1141 0.008 
Pseudo-Arteriole 6.433 × 10−10 1050 0.003675 
Arteriole: 
representative 
scale 
Artery: 
experimental 
scale 
Approx. 34 mm Approx. 0.034 mm 
Figure 2: Flow pathlines for the artery and pseudo-arteriole. 
could lead to undesirable effects. However, as the target drug delivery area will generally be 
attached to capillaries, enhanced propensity for interaction of particles with the capillary walls is a 
positive trait which will encourage penetration of, the cancerous cells requiring treatment. 
The markedly different flowfields in the geometry at experiment-scale for the artery, and scaled 
down to that approximate to an arteriole branching into capillaries, is highlighted in figure 2. The 
relatively high Reynolds number in the artery (approx. 485 based on inlet area) produces a 
considerable amount of swirling flow as the curvatures of the geometry induce areas of significant 
rotation. This is particularly clear in the ECA and following the stenosed region in the ICA, 
meaning that the flow has a high rotational component in the outlet channels. 
Because of the greatly reduced flow rate in the small scale pseudo-arteriole, the Reynolds 
number is less than 1 and therefore the flow is essentially viscosity-dominated Stokes flow, with no 
major flow features deviating from the general path the geometry describes. The shear layers are 
significantly thicker than in the artery case, presenting an essentially fully-developed profile 
throughout the channel. 
2. METHODOLOGY 
2.1. Numerical Method 
The commercial solver Fluent 12.1 was used to produce all the original results presented in this 
paper. All simulations were run in 64-bit double-precision with node-based gradient evaluation in 
a pressure-based segregated algorithm (SIMPLEC formulation). Various discretization schemes 
were evaluated, primarily to select an approach that would yield reliable steady-state results 
without compromising accuracy. When an attempt was made to use pure second-order upwinding 
for the pressure and momentum terms, the solution for the artery flow tended to fluctuate on a very 
small scale as a result of the solver failing to find an exact mass balance. While this may be 
physically-based in a small unsteadiness in the flow, the experimental data was reported as being 
fully steady-state, and in using a PRESTO! scheme for pressure discretization and a power law 
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expression for the momentum term, a satisfactory steady-state solution was obtained with 
acceptable convergence. 
While not typically applied to low-speed flows, the PRESTO! scheme (PREssure Staggering 
Option) is reported as performing well for swirling flows and flows in strongly curved domains 
[20], and follows the same general principles as staggered-grid schemes more commonly applied 
to fully-structured meshes [21]. The Power Law scheme applies a relatively straightforward linear 
interpolation to face values which offers a slight improvement to first-order upwinding, while 
acceptably damping the fluctuations present with second-order upwinding. While considerable 
extra investigation would be required in order to develop an approach which is more effective still, 
the level of flow accuracy achieved was deemed to be sufficient for the purposes of this study, as 
is shown in the following section. 
For this preliminary study into nanoparticle transport, a simple one-way Lagrangian coupling 
was used, with the particle concentration deemed to be suitably low (<1%) so as not to significantly 
alter the fluid properties. This approach also assumes there are no major particle-particle 
interactions. More importantly, the method neglects the considerable influence of red blood cells, 
though at the arteriole-into-capillary scale, this is a reasonable assumption as the cells generally 
pass single-file into the capillaries and thus a region of fluid between cells will contain only fluid 
and particles for a relatively large volume. The simplification of the problem further neglects 
thermophoretic forces and any attractive forces between particles, and wall interactions are treated 
as simple reflections. 
As the particles are sufficiently small enough for Saffman lift and Brownian motion to become 
influential, the model incorporates these effects. For the purposes of this investigation, we assume 
that the Basset history, the virtual mass, and the Faxen correction are much smaller than the drag 
force acting on any isolated individual particle of this size [22]. The Brownian aspect is modeled 
as a Gaussian white noise after Li and Ahmadi [22]. 
The Brownian force components are thus of the form: 
V 
π oFb = ζi S i ∆t 
where ζi are zero-mean, unit-variance-independent Gaussian random numbers and S is the spectralo 
intensity. 
The Saffman lift due to shear is incorporated based on the formulation of Li and Ahmadi: 
1 2 2Kv / ρdij  F = 1 4  ( − )ρ d d d  ( ) / p p p  lk  kl  
where K = 2.594 and dij is the deformation tensor: 
dij = 1 2 (ui j , + u j i , ) 
A basic determination of the influence of particle size was made based on predictions from the 
standard spherical drag of the Stokes-Cunningham formulation, which can be expressed as: 
18µF = D d2ρ Cp p  c  
where C is the Cunningham correction based on the molecular mean free path [23] – this is
c 
effectively 1 in the present case due to the relatively high density of the fluid. 
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For simulations involving particle Brownian motion, 100 separate particle release operations 
were conducted, with each of these operations involving the passive injection of approximately 
4000 particles into the fluid from a plane close to the inlet. From the computed particle track 
statistics, means for minimum, maximum and mean particle residence time for particles travelling 
through the ICA and ECA were calculated. A standard deviation was deduced from this data and 
the addition of a further 100 tracking operations altered this deviation by less than 1% and the 
means by a negligible amount, thus showing that the original 100 operations were sufficient to 
gather reliable statistical data. With approximately 4000 particles tracked in each instance, the 
mean residence times were therefore based on around 4 × 105 individual particle paths. 
The following sections establish the effectiveness of the numerical method in reproducing the 
reference experimental results [19], and present flowfields from simulations scaled to actual-artery 
and capillary size. Features of nanoparticle transport through these geometries are then discussed. 
Extensive testing revealed that the numerical flowfield was borderline unsteady, given the 
large number of recirculating regions and areas of strong velocity gradients, and therefore 
quite mesh-sensitive. A true second-order steady state solution was possible given 
considerable under-relaxation of the pressure and momentum variables on coarse and medium 
meshes at the start of the solution process, but the fine mesh retained some very minor flow 
instability. However, in all cases, an overall better match to experimental results with stable 
convergence was produced using a PRESTO! (Pressure Staggering Option) discretization for 
the pressure term and a power law spatial discretization scheme. All results quoted in the 
following sections were produced in this manner. 
2.2. Validation 
The experiments of Cheung et al. form the basis of the validation for the present study, as the 
geometry used here is identical apart from some extension to the inlet and outlet to aid with 
numerical stability at the inlet and outlet. The high level of rotation seen in the outlet channels in 
figure 2 was the most likely reason for difficult convergence with a shorter outlet region. As the 
flow was essentially fully-developed upon arrival at the MRI-derived geometry in the experiment, 
this alteration was not influential to the comparison flowfield, and the additional computational 
expense of the extended inlet and outlet was justified by improvements to convergence. 
The flow is assumed to be laminar at all points, although it is likely that transition occurred at 
the stenosis, where the local Reynolds number is well in excess of 2000. Experimental data in this 
region was not reliable, however, and for the purposes of the present investigation the transition is 
not an important feature, as particle transport in turbulent arterial flows is worthy of its own 
investigation. 
Numerical results reported in the reference paper ([19]) were produced using a relatively similar 
approach to that adopted for the present study. In that instance, the Fluent code was used featuring 
meshes with a maximum of 1.52 × 106 cells in the finest mesh, which was stated as producing 
“grid-independent” results due to a difference of less than 0.2% in maximum velocity through the 
stenosed region compared to that predicted by a mesh of 0.29 × 106 cells. Second-order upwinding 
was used to produce those results, but it should be noted that the near wall region did not feature 
any special mesh treatment to resolve the boundary layer in detail as it does in the present study. 
The numerical match to experimental results was mixed, with a strong tendency to over-prediction 
of axial velocities, particularly in the ECA, of margins as high as 30–55% in some places. The 
overall trends were reasonably well predicted at most reference points, however. 
Coarse, medium and fine meshes were constructed for the present study using a hybrid approach 
clustering anisotropic prism mesh in the boundary layer region and utilizing relatively uniform-size 
tetrahedral cells in the remaining body of the volume. Some more concentrated local refinement 
was introduced at the bifurcation and the stenosed region to better resolve the strong gradients 
there, as seen in figure 3, which depicts a general overview of the standard mesh. 
The meshes were not refined linearly, but rather incrementally in terms of surface and volume 
cell size. The mesh spacing growing tangential to the wall was kept relatively constant, as it was 
appreciated that particle/wall interactions would be particularly sensitive to the resolution in this 
region and it would have to be relatively fine whatever the cell density elsewhere. The coarse mesh 
contained a total of 3.31 × 106 cells, the standard mesh a total of 5.36 × 106, and the fine mesh a 
total of 10.32 × 106 cells. 
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Inlet detail 
Figure 3: The standard mesh, 5.36 × 106 volume cells. 
A 
B 
C 
D 
ICA ECA 
CCA 
Figure 4: Locations for numerical comparison to experimental velocity profiles. 
Figure 4 depicts the artery geometry showing locations of cuts where streamwise velocity 
profiles were extracted, on a plane which intersects the majority of the domain. These cuts match 
those reported in literature, though we note here that the plane location at cut D exists closer to the 
artery wall than the thickness of the laser light sheet (2 mm), and therefore the experimental data 
in this location is not treated as reliable and is ignored in the present study. 
It is clear from the results shown in fig. 5 (particularly in the boundary layer at cut c) in the ECA) 
that true mesh-independence has not been achieved with the fine mesh, even with close to an order 
of magnitude more cells than the finest mesh reported in the original comparison in literature [19]. 
However, improvements on that study have been achieved, with the majority of comparison points 
offering improved agreement with the experiments. There are still significant discrepancies, 
however, with the mis-match between numerical and experimental data (featuring both over- and 
under-prediction at points) in the CCA at comparison A having a knock-on effect for the rest of the 
flowfield downstream. At this initial stage, all three meshes predict very similar velocity profiles, 
with the fine mesh marginally closer to the peak velocity. At comparison point B, following the 
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Figure 5: Velocity profiles compared to experimental results for coarse, standard and 
fine meshes, taken at the locations indicated in figure 4. 
bifurcation of the artery, the three meshes again offer similar profiles in the ICA but the coarse mesh 
under-predicts the peak velocities in the ECA by a wider margin. This trend is repeated in the ECA 
at comparison C, where the three meshes produce markedly different profiles and only the fine 
Journal of Computational Multiphase Flows 
93 Graham Doig, Guan H. Yeoh and Victoria Timchenko 
mesh is close to describing the peak velocities there. In the ICA at cut C, all meshes greatly over­
estimate the velocity profile from z/ZL = 0 to at least 0.4, with a closer match over the remaining 
portion, possibly as an exaggeration of the trend which began at cut B. At cut D the standard and 
fine meshes predict the ECA profile relatively well considering earlier discrepancies, but the coarse 
mesh has a velocity bias towards the wall at z/ZL = 0 that produces a poor match up to z/ZL = 0.3. 
In the ICA, the coarse mesh is clearly inadequate for resolving the velocity profile. With a very 
narrow channel and very few mesh points to describe the flowfield, the lowest-velocity portions 
of the shear layers are exaggerated and merge causing a relatively low velocity at the point of 
maximum constriction, whereas the higher resolution of the standard and fine meshes indicate a 
considerably higher velocity peak. 
Overall, while the trends are generally well repeated with the standard and fine meshes, with 
the fine mesh offering the preferred comparison to the experiment, there are areas where the 
numerical results offer relatively poor correlation. In perspective, however, the present modeling 
offers an improvement over that reported in literature, and indeed it must be noted that the 
experimental results do not quote any reliable measure of error despite some of the 
measurements being obtained in the boundary layers close to the walls (particularly at ECA c) 
and ICA d)). For the purposes of examining nanoparticle transport, the comparisons were 
deemed to be satisfactory with the fine mesh, and thus all results reported in the following 
section were created using this approach. 
The pseudo-arteriole, as already mentioned, offered a very different flow regime from that found 
in the artery. Comparison experiments were not available for this Reynolds number, and the three 
meshes produced near-identical results due to the much larger shear layers and lack of vertical flow 
behaviour. The standard mesh was used in this instance as the flowfield is markedly more simplistic 
than in the artery case, featuring no recirculation zones or indeed any significant rotational 
behaviour. Velocity profiles, as with the artery but at the smaller scale, are presented in figure 6 for 
reference and to highlight the different flow behaviour as compared qualitatively to the artery, 
including the lack of any major velocity peak at the “stenosed” region. 
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Figure 6: Velocity profiles for pseudo-arteriole at equivalent positions to those 
shown in fig. 4. 
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3. RESULTS 
3.1. Artery, Experiment Scale 
The results presented are focused around particle residence time, which is the total time spent in 
the geometry from inlet to outlet. This parameter is of interest to designers of nanoparticles for drug 
delivery as it not only determines how swiftly the particles will navigate the vasculature to arrive 
at the site of interest, but can determine how long particles will stay in the entire bloodstream if 
circulating throughout the body and therefore may determine the extent of any toxic side-effects. 
Figure 7 indicates that the average residence time for the particles in the artery reduces with a 
corresponding reduction in particle diameter, with total residence time for a 50 nm particle being 
around 13% less than that for the 500 nm particle in the ICA and 9% less in the ECA. Clearly the 
region of highly-accelerated flow through the stenosis in the ICA reduces the average residence 
time for all particles compared to the passage through the ECA, but the reduced drag of the smaller 
particles means that the effect is more pronounced in the ICA. 
These trends are not surprising, but these overall mean values mask some more pronounced 
effects. Looking at the mean values (for all 100 trajectory tracking operations) for maximum and 
minimum particle residence time, as non-dimensionalised against the overall mean of all particles 
over all trajectory tracking operations, some more interesting trends can be observed in figure 8. 
While minimum particle residence time in both branches stays the same in absolute terms, the 
reducing mean residence times results in the minimum residence time increasing relative to the 
mean with reducing particle diameter, by approximately 9% in the ICA. Conversely, the maximum 
residence time decreases markedly (in absolute and non-dimensionalised frames of reference) from 
500 nm particles to 300 nm particles (by close to 50%). Similar characteristics are observed for the 
particles travelling through the ECA, where the reduction in maximum residence time is not as 
pronounced as in the ICA, particularly when comparing the change from 500 nm to 300 nm and 
from 300 nm to 100 nm, but from 500 nm to 50 nm the t /t drops by close to 45%.
max mean 
Several factors are behind these trends. Firstly, as figure 9 indicates, the number of particles 
experiencing one or more wall interactions significantly increases as the particle diameter is 
reduced. The percentage essentially doubles when comparing 500 nm to 50 nm particles. While the 
current model treats these interactions as simplistic reflections, it is clear that this produces 
conservative results as particle/wall interactions in actual vasculature would be more complex and 
potentially trap a large percentage of these interacting particles – precisely the trait which makes 
t (s
) 
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Figure 7: Mean particle residence time (absolute) vs. particle diameter in the artery 
(experiment scale). 
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Figure 8: Minimum (tmin) and maximum (t ) particle residence times non-max
dimensionalised against the mean vs. particle diameter. 
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Figure 9: Percentage of particles experiencing one or more wall interactions vs. particle 
diameter. 
smaller particles desirable to researchers looking to target tumours in certain organs. The increase 
in wall interactions is due to the Brownian influence on particle motion; smaller particles are more 
highly influenced due to the larger Brownian force moving them across streamlines into the slow-
moving fluid next to the walls. Here, Brownian diffusion is more pronounced than the advective 
transport of particles travelling in the fast-moving fluid in the middle of the volume. 
For particles which are able to move away from the walls from the lift due to shear, the lack of 
further wall interactions plus the move to faster moving flow in the middle of the channel combines 
with the reduced drag of the smaller particles to greatly reduce the maximum residence time. The 
enhanced influence of the Saffman lift on small particles is evident in this respect, though the 
increased number of wall interactions indicates that the effect is gradual. 
To better understand the role Brownian motion plays in influencing the trajectories of particles 
of differing sizes, the results in figure 10a for the ICA and figure 10b for the ECA are presented in 
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Figure 10: Max., min. and mean residence times for particles with Brownian motion (tb), 
non-dimensionalised against values from non-Brownian particles (t), vs. particle 
diameter for a) ICA and b) ECA branches. 
terms of maximum and minimum particle residence time as non-dimensionalised against the 
comparison residence time for particle paths without Brownian motion. From these graphs it is 
clear to see that the minimum residence time is negligibly affected by Brownian motion; as stated 
previously, the flow is moving too quickly to allow the Brownian influence to change the particle 
trajectory by any meaningful degree, and the particles are too small to suffer any meaningful 
retardation in the high-velocity regions. 
The mean residence time for the cases with Brownian motion is actually reduced compared to 
cases without, and indeed decreases by a greater margin with reducing particle diameter, which 
initially seems counter-intuitive. However, this may be explained in part by the wall interactions 
which occur in the Brownian cases but not in the reference cases. The particles involved in such 
interactions will tend to rebound into the fluid with energy which will enhance their ability to be 
lifted, even slightly, away from the slowest flow next to the wall and into the faster-moving fluid 
closer to the middle of the channel. This compares to the non-Brownian case, where the particles 
can remain trapped close to the wall for the duration of their time in the artery. 
The increased flow acceleration in the stenosis of the ICA exaggerates the trend for particles in 
that branch, as the accelerated particles are less likely to marginate again once passing through the 
narrowest section. In these simulations there is a therefore general reduction in maximum residence 
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time, however in a real situation a potentially-greater proportion of the particles wouldbecome 
trapped at the wall and thus be removed from circulation within the body – generally an undesirable 
outcome for an artery, but a positive trait for particles in slow-moving fluid in the vicinity of 
cancerous cells. 
As an aside, the results indicate that the lower limit for size of seeding particles for experimental 
fluid-only work on geometries such as the artery, involving laser-measurement approaches such as 
PIV and LDA, must be considerably higher than 500 nm if the results are to be accurate and free 
of undue wall interactions and excessive influence from Brownian motion and particle lift due to 
the shear flow close to the boundaries. 
3.2. Pseudo-Arteriole 
With the geometry scaled down markedly from the artery case (preserving the relative mesh as 
identical) such that the region of maximum constriction is just 6 microns, the trends observed in the 
previous section do not necessarily hold in the flow conditions of the pseudo-arteriole. With the 
Reynolds number less than one for flow entering the bifurcated channels, which we will refer to as 
capillaries in the spirit of the scale, the Saffman lift due to shear is not particularly influential, but 
the Brownian diffusion of the particles is considerable in the low-velocity flowfield.  The latter 
characteristic is reflected in figure 11, which highlights a slight increase in mean residence time as 
particle diameter is reduced from 500 nm to 100 nm, and a more marked increase from 100 nm to 
50 nm. The Peclet number is approximately three orders of magnitude less than for the artery, 
indicating a much higher influence of particle diffusion relative to advection. 
Unlike the artery case, where minimum residence time was unaffected by changes to particle 
diameter, the minimum residence times in the pseudo-arteriole case decrease slightly in absolute 
terms. The maximum residence time reduces by a more significant percentage with increases in 
particle diameter. Non-dimensionalising these parameters against the mean as before, in figure 12, 
indicates that the maximum residence in the “ECA” branch increases with reducing particle 
diameter from 500 nm to 100 nm, but then reduces sharply from 100 nm to 50 nm, while in the 
“ICA” branch the maximum residence time decreases consistently as the particle diameter shrinks. 
In both branches of the geometry, the minimum residence time reduces. 
Figure 13 highlights the percentage of particles involved in one or more wall interactions, and 
although the trend of increased interaction with decreased particle diameter seen in the artery case 
holds, the percentages are much higher, with over 33% of all 50 nm particles meeting the wall at 
some point. This compares to just over 18% for 500 nm particles. Clearly the Brownian influence 
is inducing these interactions in a much more pronounced fashion than at the larger scale and higher 
Reynolds number. 
t (s
) 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0 
Mean residence time, pseudo-ICA 
Mean residence time, pseudo-ECA 
0 100 200 300 400 500 600 
Particle diameter (nm) 
Figure 11: Mean particle residence time (absolute) vs. particle diameter. 
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Figure 12: Minimum (tmin) and maximum (t ) particle residence times, non-max
dimensionalised against the mean (t ), vs. particle diameter. mean
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Figure 13: Percentage of particles experiencing one or more wall interactions vs. particle 
diameter. 
With particles of smaller diameter, the relative disturbance to particle trajectory due to this 
effect is stronger and thus particles closer to the wall are far more likely to have the Brownian force 
overcome other forces acting on it to keep it from the boundary. 
Characterising the strong influence of Brownian motion on the particles compared to those in 
cases run without this effect, in figure 14a for the “ICA” and figure 14b for the “ECA”, one can see 
that the maximum residence time for the Brownian cases is markedly higher, undoubtedly due to 
the increased length of the overall particle trajectories due to the additional deviations. As particle 
diameter reduces from 500 nm to 50 nm, so too does the relative maximum residence time, though 
it does not approach the non-Brownian level. In the “ECA” case, as also noted for figure 12, the 
maximum residence actually increases with reducing particle diameter from 500 nm to 100 nm, 
before the overall trend is restored at 50 nm. 
The minimum residence time in both channels reduces by a small margin with Brownian motion 
compared to the particles without; most likely a function of the wall reflections, as with the artery, 
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Figure 14: Max., min. and mean residence times for particles with Brownian motion (tb), 
non-dimensionalised against values from non-Brownian particles (t), vs. particle 
diameter for a) ICA  and b) ECA  branches. 
inducing the particles to move back into the shear layer rather than hold station in the slowest-
moving fluid near the wall. 
4. CONCLUSIONS 
A preliminary numerical study into nanoparticle transport in a bifurcated carotid artery, and a 
scaled-down version approximating an arteriole and branch capillaries, has been conducted to 
establish the influence of size on the trajectory and residence time of particles. Diameters of 
500 nm, 300 nm, 100 nm and 50 nm were investigated using a simple one-way fluid coupling. In 
the case of the artery, a decrease in particle size was accompanied by a decrease in mean particle 
residence time. The minimum residence time was generally unaffected but the maximum residence 
time dropped sharply with reducing particle size, primarily because of the lower drag and 
considerably higher influence of Saffman lift on the smaller. The percentage of particles 
experiencing wall interactions effectively doubled with particle diameter reducing from 500 nm to 
50 nm to 8.4%. 
In the pseudo-arteriole, where the conditions are essentially those of Stokes flow, the mean 
residence time increases by approximately 3% with reducing particle diameter from 500 nm to 
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50 nm, primarily due to the increased influence of Brownian motion as the mass is reduced. 
However, both the minimum and maximum residence times decreased. At 500 nm, 18% of particles 
experienced wall interactions, whereas this figure for the 50 nm particles was closer to 33%. Again, 
this highlights the significant influence of Brownian motion on the smallest particles closest to the 
walls. 
This initial study highlights the importance of particle size for the efficacy of nanoparticle drug 
delivery, and the work is currently being extended to a transient flow imitating systolic pulsatile 
flow, where Brownian diffusion plays a much stronger role even in the artery during stages where 
the peak flow velocity is close to zero. Methods of four-way coupling are being implemented which 
will provide a means by which to incorporate particle attraction forces and more realistic 
agglomeration effects and accretion at the wall. 
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